Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04179955 · ClinicalTrials.gov registry record

Intraoperative Costs and Patient Perceptions in Sacrocolpopexy for Prolapse

A clinical trial of Pelvic Organ Prolapse, sponsored by Mayo Clinic.

Active
Registry status
80
Enrollment target
1
Study location

NCT04179955 is a study of Pelvic Organ Prolapse that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 143-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04179955, a study of Pelvic Organ Prolapse, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

Robotic sacrocolpopexy (a procedure for female pelvic organ prolapse) has been demonstrated to have equivalent surgical outcomes to open abdominal sacrocolpopexy and has been previously deemed more cost effective due to the longer hospital course following open procedures. The total cost of these procedures, including all costs of hospitalization as well as costs associated with the 30 days following surgery have previously been evaluated by the investigators. However, previous research is lacking in both the specific cost components that contribute to intraoperative cost of surgery as well as the patient perceived outcomes following these two procedures. This project aims to evaluate the marginal costs of surgery and to survey sacrocolpopexy patients to evaluate their satisfaction with outcomes and surgical scars.

Conditions Studied

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2019-12-10
Est. Completion 2025-12

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04179955

The ClinicalTrials.gov registry entry for NCT04179955 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 143-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (44% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 0 interventions.

NCT04179955 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04179955 about?

NCT04179955 is a clinical study titled "Intraoperative Costs and Patient Perceptions in Sacrocolpopexy for Prolapse". Robotic sacrocolpopexy (a procedure for female pelvic organ prolapse) has been demonstrated to have equivalent surgical outcomes to open abdominal sacrocolpopexy and has been previously deemed more cost effective due to the longer hospital course following open procedures. The total cost of these pr...

What is the current status of trial NCT04179955?

This trial is currently active not recruiting. The enrollment target is 80 participants. The study started on 2019-12-10. Estimated completion is 2025-12.

What conditions does trial NCT04179955 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse.

Who is sponsoring clinical trial NCT04179955?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04179955 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.